Dynavax Technologies (DVAX) Cash & Current Investments: 2009-2025
Historic Cash & Current Investments for Dynavax Technologies (DVAX) over the last 17 years, with Sep 2025 value amounting to $647.8 million.
- Dynavax Technologies' Cash & Current Investments fell 15.21% to $647.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.6 billion, marking a year-over-year decrease of 11.09%. This contributed to the annual value of $713.8 million for FY2024, which is 3.84% down from last year.
- Dynavax Technologies' Cash & Current Investments amounted to $647.8 million in Q3 2025, which was up 5.55% from $613.7 million recorded in Q2 2025.
- Dynavax Technologies' Cash & Current Investments' 5-year high stood at $764.0 million during Q3 2024, with a 5-year trough of $232.7 million in Q1 2021.
- Over the past 3 years, Dynavax Technologies' median Cash & Current Investments value was $713.8 million (recorded in 2024), while the average stood at $696.0 million.
- As far as peak fluctuations go, Dynavax Technologies' Cash & Current Investments soared by 230.81% in 2021, and later decreased by 16.57% in 2025.
- Dynavax Technologies' Cash & Current Investments (Quarterly) stood at $546.0 million in 2021, then climbed by 14.37% to $624.4 million in 2022, then increased by 18.88% to $742.3 million in 2023, then fell by 3.84% to $713.8 million in 2024, then fell by 15.21% to $647.8 million in 2025.
- Its Cash & Current Investments stands at $647.8 million for Q3 2025, versus $613.7 million for Q2 2025 and $661.3 million for Q1 2025.